CTA Can Diagnose Partially Obstructed IVC in Budd-Chiari

Share this content:
CTA Can Diagnose Partially Obstructed IVC in Budd-Chiari
CTA Can Diagnose Partially Obstructed IVC in Budd-Chiari

FRIDAY, Dec. 16, 2016 (HealthDay News) -- For patients with Budd-Chiari syndrome (BCS), computed tomographic angiography (CTA) has high diagnostic accuracy for partially obstructed inferior vena cava (IVC), according to a study published online Nov. 29 in the Journal of Gastroenterology and Hepatology.

Shi-Yi Liu, from Zhongnan University in Changsha, China, and colleagues examined the diagnostic accuracy of CTA for patients with BCS and a partially obstructed IVC. Three hundred twenty-nine patients were treated endovascularly with balloon dilation and/or stent placement. Prior to endovascular treatment all patients underwent a CTA examination.

The researchers found that based on digital subtraction angiography, 108 patients had a partially obstructed IVC and 221 patients had a complete obstruction. Using CTA, 99 patients exhibited a partially obstructed IVC and 230 had a completely obstructed IVC. With the CTA results there were 15 and six false negatives and false positives, respectively. For the detection of BCS with a partial IVC obstruction, the patient-based evaluation yielded an accuracy of 93.6 percent, sensitivity of 86.1 percent, specificity of 97.3 percent, positive predictive value of 93.9 percent, and negative predictive value of 93.5 percent.

"CTA offered a high diagnostic accuracy and sensitivity in BCS patients with a partially obstructed IVC," the authors write. "The low-density area within the enhanced proximal IVC above the membrane in artery phase can be considered a reliable indicator of a stenotic IVC in BCS patients."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters


More in Home

AAN: Erenumab Shows Promise for Hard-to-Treat Migraine

AAN: Erenumab Shows Promise for Hard-to-Treat Migraine

Higher proportion of patients achieved a ≥50 percent reduction in mean monthly migraine days

AAN: New Drug May Help Infants With Spinal Muscular Atrophy

AAN: New Drug May Help Infants With Spinal ...

RG7916 increases survival motor neuron protein level, with 6.5-fold increase noted with highest dose

Small Link for Cannabis Use, Reduced Cognitive Functioning

Small Link for Cannabis Use, Reduced Cognitive Functioning

Small overall effect size for frequent and heavy cannabis use among adolescents, young adults

is free, fast, and customized just for you!

Already a member?

Sign In Now »